DMSI
Healthcare Medical DevicesDermisonics, Inc.
$0.00
-0.00 -100.00% today
Price History
Not enough data
Key Stats
Market Cap
0
Avg Volume
0
EPS
-$0.44
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%
Valuation
P/B Ratio
-0.00
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Equity
(392.2%)
Return on Assets
(12.1%)
Liquidity & Leverage
Current Ratio
0.01
Quick Ratio
0.01
Total Cash
22,766
Total Debt
2.65M
About
Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.